Engineers Gate Manager LP

Position in TBPH — Theravance Biopharma, Inc.

CIK 1620220 NEW YORK, NY

Position in TBPH

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$1,702,312

-$135,264 QoQ

Shares Held

100,136

-11.6% QoQ

Ownership

0.193%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

#45

of 179 holders

Holding Since

Mar 2020

14 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Engineers Gate Manager LP holds $199,313,913 across 163 Biotechnology names. TBPH ranks #32 (0.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	INSM	INSMED Inc	126,044	$13,438,811
2	BMRN	Biomarin Pharmaceutical Inc	181,647	$10,393,841
3	ALNY	Alnylam Pharmaceuticals, Inc.	33,469	$10,075,173
4	REGN	Regeneron Pharmaceuticals, Inc.	15,918	$9,925,509
5	RPRX	Royalty Pharma plc	137,994	$7,737,323
6	EXEL	Exelixis, Inc.	110,353	$6,004,306
7	ONC	BeOne Medicines Ltd.	16,302	$4,645,580
8	VERA	Vera Therapeutics, Inc.	108,139	$4,640,244

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,702,312	100,136	-11.6%	Shares	Sole	2026-08-14
2026-03-31	$1,837,576	113,221	+176.1%	Shares	Sole	2026-05-15
2025-12-31	$767,259	41,008	+84.0%	Shares	Sole	2026-02-17
2025-09-30	$325,361	22,285	+63.2%	Shares	Sole	2025-11-14
2025-06-30	$150,636	13,657	-31.1%	Shares	Sole	2025-08-14
2024-12-31	$186,619	19,832	-26.6%	Shares	Sole	2025-02-14
2024-09-30	$217,821	27,025	+38.8%	Shares	Sole	2024-11-14
2024-06-30	$165,164	19,477	+63.4%	Shares	Sole	2024-08-14
2024-03-31	$106,931	11,921	-52.3%	Shares	Sole	2024-05-15
2023-12-31	$280,763	24,979	+35.2%	Shares	Sole	2024-02-14
2021-09-30	$136,766	18,482	+2.4%	Shares	Sole	2021-11-15
2020-12-31	$320,766	18,051	-75.5%	Shares	Sole	2021-02-16
2020-06-30	$1,546,270	73,667	+81.4%	Shares	Sole	2020-08-17
2020-03-31	$938,751	40,621	—	Shares	Sole	2020-05-15
No filing history on record for this holder in this stock.